Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-risk Non Muscle Invasive Bladder Cancer.

MLA

Kageyama, Susumu, et al. “Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-Risk Non Muscle Invasive Bladder Cancer.” In Vivo, vol. 35, no. 2, Mar. 2021, pp. 1141–45. EBSCOhost, https://doi.org/10.21873/invivo.12360.

APA

Kageyama, S., Maeda, K., Kubota, S., Yoshida, T., Osafune, T., Arai, Y., Soga, H., Nishikawa, Z., Sakano, Y., Takimoto, K., Kim, C. J., Chano, T., & Kawauchi, A. (2021). Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-risk Non Muscle Invasive Bladder Cancer. In Vivo, 35(2), 1141–1145. https://doi.org/10.21873/invivo.12360

Chicago

Kageyama, Susumu, Koki Maeda, Shigehisa Kubota, Tetsuya Yoshida, Takashi Osafune, Yutaka Arai, Hiroki Soga, et al. 2021. “Single Short Retention Instillation of Pirarubicin Prevents Intravesical Recurrence of Low-Risk Non Muscle Invasive Bladder Cancer.” In Vivo 35 (2): 1141–45. doi:10.21873/invivo.12360.